Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cerebrospinal Fluid Biomarkers of Myotonic Dystrophy

NCT06075693 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT06075693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06075693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cerebrospinal Fluid Biomarkers of Myotonic Dystrophy
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Recruiting
Start date
August 1, 2022
Completion date
August 1, 2028
Enrollment
88 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myotonic dystrophy type 1